Combination therapy using human papillomavirus L1/E6/E7 genes and archaeosome: a nanovaccine confer immuneadjuvanting effects to fight cervical cancer

Cancer is a leading cause of death worldwide. Cervical cancer caused by human papillomavirus (HPV) is a major health problem in women. DNA vaccines are a perfect approach to immunization, but their potency in clinical trials has been insufficient for generating effective immunity, which may be relat...

Descripción completa

Detalles Bibliográficos
Autores principales: Karimi, Hesam, Soleimanjahi, Hoorieh, Abdoli, Asghar, Banijamali, Razieh Sadat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113280/
https://www.ncbi.nlm.nih.gov/pubmed/32238821
http://dx.doi.org/10.1038/s41598-020-62448-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113280/
https://www.ncbi.nlm.nih.gov/pubmed/32238821
http://dx.doi.org/10.1038/s41598-020-62448-3

Ejemplares similares